Dr. Clemens M. Doppler

Clemens M. Doppler is Managing Partner of HeidelbergCapital. Prior he was a Partner at 3i and has worked in various markets and geographies. He specialises in life science and emerging technologies and managed more than 100 million USD for 3i. He worked at Boehringer Mannheim (now Roche) before he joined one of the first Swiss Biotech companies as executive, which was successfully sold in 1997 to MDS, Inc (former Phoenix International Life Science, Montreal & NJ .), a world leading Pharma services provider. Clemens currently serves on the board of 4SC, Accovion, MerLion, Sensovation and Vasopharm. Clemens graduated from the Ruprecht-Karls-University of Heidelberg/Germany as a Master of Science in Biology and a Ph.D. in Molecular Biology from the German Cancer Research Center.